| Access Family Care | |
|
2209 Oak Ridge Dr Neosho MO 64850-9092 | |
| (417) 451-0977 | |
| (417) 451-7094 |
| Full Name | Access Family Care |
|---|---|
| Speciality | Clinic/Center |
| Location | 2209 Oak Ridge Dr, Neosho, Missouri |
| Authorized Official Name and Position | Don M Mcbride (CEO) |
| Authorized Official Contact | 4174519450 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Access Family Care Po Box 758 Neosho MO 64850-0758 Ph: (417) 451-9450 | Access Family Care 2209 Oak Ridge Dr Neosho MO 64850-9092 Ph: (417) 451-0977 |
| NPI Number | 1013368984 |
|---|---|
| Provider Enumeration Date | 06/22/2016 |
| Last Update Date | 11/04/2022 |
| Medicare PECOS PAC ID | 8123918257 |
|---|---|
| Medicare Enrollment ID | O20161201000534 |
News Archive
A group of Democratic governors was expected to send a letter Monday opposing key proposals to overhaul Medicaid. Meanwhile, some advocates for seniors and children are taking exception to Ryan's ideas about revamping Medicare into a voucher program and other steps they say will will put vulnerable populations at risk.
Two new studies available online and being published in the April edition of the American Journal of Preventative Medicine find that electronic cigarettes produces abstinence rates nearly double that of traditional nicotine replacement methods and that consumer interest in e-cigarettes is currently much higher than interest in traditional nicotine replacement products.
Turning off a protein that helps cells balance energy increases animal mobility and reduces the death of nerve cells that control movement in animal models of amyotrophic lateral sclerosis (ALS), according to a study in the January 18 issue of The Journal of Neuroscience. The findings may one day guide new directions for the treatment of the progressive neurodegenerative disorder, for which there is currently no cure.
Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl (APIS), announced today that the Paul-Ehrlich-Institut, Germany's healthcare regulatory body for biological products, has authorized initiation of an open-label clinical trial to investigate eculizumab as a treatment for patients with Shiga-toxin producing E. coli hemolytic uremic syndrome, which has resulted from infections by Enterohemorrhagic Escherichia coli in an unusually wide outbreak in Germany that began in May.
New research published in Schizophrenia Research conducted at the University of Liverpool links brain structure to an individual's likelihood of experiencing hallucinations and to their musical aptitude.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013368984 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
A group of Democratic governors was expected to send a letter Monday opposing key proposals to overhaul Medicaid. Meanwhile, some advocates for seniors and children are taking exception to Ryan's ideas about revamping Medicare into a voucher program and other steps they say will will put vulnerable populations at risk.
Two new studies available online and being published in the April edition of the American Journal of Preventative Medicine find that electronic cigarettes produces abstinence rates nearly double that of traditional nicotine replacement methods and that consumer interest in e-cigarettes is currently much higher than interest in traditional nicotine replacement products.
Turning off a protein that helps cells balance energy increases animal mobility and reduces the death of nerve cells that control movement in animal models of amyotrophic lateral sclerosis (ALS), according to a study in the January 18 issue of The Journal of Neuroscience. The findings may one day guide new directions for the treatment of the progressive neurodegenerative disorder, for which there is currently no cure.
Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl (APIS), announced today that the Paul-Ehrlich-Institut, Germany's healthcare regulatory body for biological products, has authorized initiation of an open-label clinical trial to investigate eculizumab as a treatment for patients with Shiga-toxin producing E. coli hemolytic uremic syndrome, which has resulted from infections by Enterohemorrhagic Escherichia coli in an unusually wide outbreak in Germany that began in May.
New research published in Schizophrenia Research conducted at the University of Liverpool links brain structure to an individual's likelihood of experiencing hallucinations and to their musical aptitude.
› Verified 9 days ago
Freeman Neosho Hospital Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 336 S Jefferson St, Neosho, MO 64850 Phone: 417-455-4200 | |
Freeman Neosho Physician Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 336 S Jefferson St, Neosho, MO 64850 Phone: 417-347-6605 | |
Free Market Physician Hospital Services, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4040 La Questa Dr, Neosho, MO 64850 Phone: 417-283-4953 | |
Access Family Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1120 Carl Sweeney Rd, Neosho, MO 64850 Phone: 417-782-6200 Fax: 417-782-6210 | |
Access Family Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1111 Wornall St, Neosho, MO 64850 Phone: 417-782-6200 Fax: 417-782-6210 | |
Access Family Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 201 N Washington St, Neosho, MO 64850 Phone: 417-782-6200 Fax: 417-782-6210 |